Silver Book Fact

The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.

Rein D, Wittenborn J, Zhang X, Honeycutt A, et al. Forecasting Age-Related Macular Degeneration Through the Year 2050. JAMA Ophthalmol. 2009; 127(4): 533-40. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/422785

Reference

Title
Forecasting Age-Related Macular Degeneration Through the Year 2050
Publication
JAMA Ophthalmol
Publication Date
2009
Authors
Rein D, Wittenborn J, Zhang X, Honeycutt A, et al
Volume & Issue
Volume 127, Issue 4
Pages
533-40
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • The cost of lost productivity due to dry eye is estimated at more than $5,000 per patient.  
  • The average cost in 2004 per age-related macular degeneration (AMD) patient age 40 and older using medications and vitamins was $110.  
  • The number of people in the U.S. with visual impairment or blindness is expected to double to more than 8 million by 2050.
     
  • Estimated Specific Prevalence Rates for AMD  
  • Around 1 in 5 individuals with diabetes in the NEI-sponsored Los Angeles Latino Eye Study (LALES) was newly diagnosed during the study. Of those who were newly diagnosed, 23% were…